Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Depressive illness and disability.

Y Lecrubier1

  • 1Hôpital La Salpêtrière, 47 Boulevard de l'Hôpital, 75651 Paris, Cedex 13, France.

European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|December 15, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Improved ability to identify symptoms of major depressive disorder (MDD) in general practice.

International journal of psychiatry in clinical practice·2014
Same author

DSM-IH-R Psychotic Disorders: procedural validity of the Mini International Neuropsychiatric Interview (MINI). Concordance and causes for discordance with the CIDI.

European psychiatry : the journal of the Association of European Psychiatrists·2009
Same author

Measures of anhedonia and hedonic responses to sucrose in depressive and schizophrenic patients in comparison with healthy subjects.

European psychiatry : the journal of the Association of European Psychiatrists·2009
Same author

Characteristics, recognition and treatment of dysthymics in primary care.

European psychiatry : the journal of the Association of European Psychiatrists·2009
Same author

The impulsivity rating scale (IRS): preliminary results.

European psychiatry : the journal of the Association of European Psychiatrists·2009
Same author

A psychopharmacological treatment algorithm for generalised anxiety disorder (GAD).

Journal of psychopharmacology (Oxford, England)·2008
Same journal

Genomic relationship between polyendocrine metabolic ovarian syndrome and bipolar disorder.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2026
Same journal

Genetic overlap between depression and C-reactive protein levels: Evidence from a cross-trait analysis.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2026
Same journal

In-patient treatment and structural dysconnectivity in major depression - A longitudinal connectome study.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2026
Same journal

Neuroimaging predictors of cognitive benefits after virtual reality-based cognitive remediation in mood or schizophrenia spectrum disorders.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2026
Same journal

Childhood maltreatment is linked to transdiagnostic age- and sex-specific cortical thinning and reduced amygdalar volume in young adults.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2026
Same journal

Functioning assessment short test for autism (FAST-A): a tool to evaluate adaptive functioning in autistic adults.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2026
See all related articles

Depression significantly impacts daily functioning and workplace productivity, causing substantial disability. Effective treatment can reduce this burden and healthcare costs, highlighting the need for better recognition and care in primary settings.

Area of Science:

  • Psychiatry
  • Public Health
  • Health Economics

Background:

  • Depression is a widespread mental health disorder causing significant functional disability, often exceeding that of other chronic conditions.
  • Depression leads to reduced workplace productivity, increased absenteeism, and high healthcare resource utilization.
  • Comorbid depression and anxiety exacerbate disability and associated costs.

Purpose of the Study:

  • To highlight the substantial burden of functional disability imposed by depression.
  • To emphasize the economic impact of depression on individuals and society, including healthcare costs and lost productivity.
  • To advocate for improved recognition and treatment of depression in primary care.

Main Methods:

  • This study is a review of existing literature and data on the impact of depression.

Related Experiment Videos

  • Analysis of functional disability metrics associated with depression and comorbid conditions.
  • Examination of economic consequences, including healthcare resource use and productivity losses.

    • Main Results:

    • Depression is a leading cause of functional disability, surpassing many chronic medical illnesses.
    • Untreated depression results in significant economic costs due to lost productivity and high healthcare utilization.
    • Treatment of depression demonstrably lowers disability levels and enhances workplace productivity.
    • Reduced healthcare resource usage following depression treatment can offset treatment costs.

    Conclusions:

    • Improving the recognition and treatment of depression in primary care is crucial.
    • Addressing depression can substantially alleviate individual suffering and societal economic burdens.
    • Timely and appropriate depression care is essential for reducing disability and improving overall societal well-being.